Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas

被引:36
作者
Finn, Olivera J. [1 ]
Gantt, Kira R. [1 ]
Lepisto, Andrew J. [1 ]
Pejawar-Gaddy, Sharmila [1 ]
Xue, Jia [1 ]
Beatty, Pamela L. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
关键词
Lung cancer; Pancreatic cancer; Cancer vaccine; Tumor-associated antigens; Mucin; CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; C-SRC; CANCER; GROWTH; CELLS; TRANSCRIPTION; PROTEIN; IMMUNITY; STRESS;
D O I
10.1007/s12026-011-8214-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many important aspects of cancer biology, such as cancer initiation, progression, and metastasis, have been studied in animal models, mostly mice. As long as cancer was considered primarily a genetic disease, the study of transplantable mouse tumors, or even human tumor xenografts in immunocompromised mice, appeared to suffice. Many important genetic events that lead to transformation and in vivo tumor growth were elucidated. However, many even more important factors that determine whether or not the genetic potential of a tumor cell will be realized, such as the host response to the tumor and the tumor microenvironment that influences this response over a long period of time of tumor development, remained untested and unappreciated. This is slowly changing with the advent of molecular techniques that have spurred efforts to engineer better mouse models of human tumors. In this review, we show results of our efforts to combine a genetic mouse model of spontaneous human adenocarcinomas based on a Kras mutation, with an important human molecule MUC1 that is abnormally expressed on human adenocarcinomas, promoting oncogenesis, proinflammatory tumor microenvironment, and immunosurveillance.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 19 条
[1]   Vaccine against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer [J].
Beatty, Pamela L. ;
Narayanan, Sowmya ;
Gariepy, Jean ;
Ranganathan, Sarangarajan ;
Finn, Olivera J. .
CANCER PREVENTION RESEARCH, 2010, 3 (04) :438-446
[2]   Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity [J].
Carlos, CA ;
Dong, HF ;
Howard, OMZ ;
Oppenheim, JJ ;
Hanisch, FG ;
Finn, OJ .
JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1628-1635
[3]   MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1 [J].
Engelmann, Katja ;
Shen, Hongmei ;
Finn, Olivera J. .
CANCER RESEARCH, 2008, 68 (07) :2419-2426
[4]   MUC1*Mediates the Growth of Human Pluripotent Stem Cells [J].
Hikita, Sherry T. ;
Kosik, Kenneth S. ;
Clegg, Dennis O. ;
Bamdad, Cynthia .
PLOS ONE, 2008, 3 (10)
[5]   Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin [J].
Li, YQ ;
Bharti, A ;
Chen, DS ;
Gong, JL ;
Kufe, D .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :7216-7224
[6]   The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and β-catenin [J].
Li, YQ ;
Ren, J ;
Yu, WH ;
Li, Q ;
Kuwahara, H ;
Yin, L ;
Carraway, KL ;
Kufe, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35239-35242
[7]   The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin [J].
Li, YQ ;
Kuwahara, H ;
Ren, J ;
Wen, GY ;
Kufe, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) :6061-6064
[8]   The ErbB signaling network: receptor heterodimerization in development and cancer [J].
Olayioye, MA ;
Neve, RM ;
Lane, HA ;
Hynes, NE .
EMBO JOURNAL, 2000, 19 (13) :3159-3167
[9]  
PANDEY P, 1995, CANCER RES, V55, P4000
[10]   Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents [J].
Ren, J ;
Agata, N ;
Chen, DS ;
Li, YQ ;
Yu, WH ;
Huang, L ;
Raina, D ;
Chen, W ;
Kharbanda, S ;
Kufe, D .
CANCER CELL, 2004, 5 (02) :163-175